On the public citation graph

Interleukin 23 is elevated in the serum of patients with SLE

https://doi.org/10.1177/0961203320952841
0 signed · 39 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/art.1780400928openalex-snapshot
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
inferredcites →https://doi.org/10.1016/j.imlet.2019.04.002openalex-snapshot
Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients
inferredcites →https://doi.org/10.1016/s0140-6736(18)32167-6openalex-snapshot
Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
inferredcites →https://doi.org/10.1038/ni.3731openalex-snapshot
The multiple pathways to autoimmunity
inferredcites →https://doi.org/10.1146/annurev.immunol.021908.132710openalex-snapshot
IL-17 and Th17 Cells
inferredcites →https://doi.org/10.1155/2013/861028openalex-snapshot
Treatment with Anti-Interleukin 23 Antibody Ameliorates Disease in Lupus-Prone Mice
inferredcites →https://doi.org/10.1155/2017/9401432openalex-snapshot
Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease
inferredcites →https://doi.org/10.1186/s12865-015-0070-7openalex-snapshot
IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
inferredcites →https://doi.org/10.3109/03009742.2014.962080openalex-snapshot
Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis
inferredcites →https://doi.org/10.3899/jrheum.100293openalex-snapshot
The Relation of Interleukin 17 (IL-17) and IL-23 to Th1/Th2 Cytokines and Disease Activity in Systemic Lupus Erythematosus
inferredcites →https://doi.org/10.4049/jimmunol.0900385openalex-snapshot
The Role of IL-23/IL-17 Axis in Lupus Nephritis
inferredcites →https://doi.org/10.4049/jimmunol.0903595openalex-snapshot
Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6– lpr/lpr Mice
inferredcites →https://doi.org/10.4049/jimmunol.1700418openalex-snapshot
IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus
inferredcites →https://doi.org/10.4049/jimmunol.181.12.8761openalex-snapshot
Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4625795openalex-extracted
Multiplex Profiling and Machine Learning Reveal Distinct Signatures of Circulating Cytokines Associated with Autoantibody Profiles and Disease Severity in Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.1002/art.42830openalex-snapshot
A Novel Human Interleukin‐23A Overexpressing Mouse Model of Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.1002/art.43395openalex-snapshot
Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis
inferred← citeshttps://doi.org/10.1007/s00011-022-01674-zopenalex-snapshot
The star target in SLE: IL-17
inferred← citeshttps://doi.org/10.1007/s12016-020-08823-4openalex-snapshot
IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
inferred← citeshttps://doi.org/10.1016/j.autrev.2026.104146openalex-snapshot
Germinal center and extrafollicular dysregulation in systemic lupus erythematosus: Mechanisms and therapeutic opportunities
inferred← citeshttps://doi.org/10.1016/j.clim.2024.110200openalex-snapshot
New and emerging therapies for systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1016/j.ejr.2021.10.009openalex-snapshot
Interleukin-23 serum level in systemic lupus erythematosus patients: Relation to disease activity and different disease parameters
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.120965openalex-snapshot
LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet's disease and systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1038/s41598-024-62265-yopenalex-snapshot
Elevated levels of IL-12/IL-23p40 in Nova Scotia Duck Tolling Retrievers with autoimmune disease and lymphoma
inferred← citeshttps://doi.org/10.1038/s41598-024-79978-9openalex-snapshot
Machine learning identifies cytokine signatures of disease severity and autoantibody profiles in systemic lupus erythematosus – a pilot study
inferred← citeshttps://doi.org/10.1080/09546634.2024.2436015openalex-snapshot
Off-label dermatologic uses of IL-23 inhibitors
inferred← citeshttps://doi.org/10.1177/09612033221090172openalex-snapshot
Interleukin 17A rs2275913 polymorphism is associated with susceptibility to systemic lupus erythematosus: A meta and trial sequential analysis
inferred← citeshttps://doi.org/10.1177/09612033221112809openalex-snapshot
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1177/09612033251345193openalex-snapshot
Commonalities between thyroid disease and systemic lupus erythematosus (SLE)
inferred← citeshttps://doi.org/10.1182/bloodadvances.2025019065openalex-snapshot
Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.2147/btt.s389021openalex-snapshot
Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices
inferred← citeshttps://doi.org/10.21608/ejmm.2023.277801openalex-snapshot
Circulating IL 6 and IL 23 Levels in Systemic Lupus Erythematosus Patients and Association with Disease Activity
inferred← citeshttps://doi.org/10.2174/0115665240290075240514164601openalex-snapshot
miRNA-21, an Important Regulator of Autoimmune Diseases
inferred← citeshttps://doi.org/10.26900/hsq.1.1.05openalex-snapshot
EVALUATION OF THE RELATIONSHIP BETWEEN IL-10, IL-17, IL-23 LEVELS AND DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS AND VITAMIN D STATUS
inferred← citeshttps://doi.org/10.3389/fphar.2022.982238openalex-snapshot
The regulatory mechanism and potential application of IL-23 in autoimmune diseases
inferred← citeshttps://doi.org/10.3390/cells11101625openalex-snapshot
Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
inferred← citeshttps://doi.org/10.3390/jcm10204788openalex-snapshot
Lack of Association between Serum Interleukin-23 and Interleukin-27 Levels and Disease Activity in Patients with Active Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.3390/jcm12175699openalex-snapshot
Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries
inferred← citeshttps://doi.org/10.35118/apjmbb.2023.031.4.01openalex-snapshot
Novel single nucleotide polymorphism (rs1600485907) of IL-41 gene associated with systemic lupus erythematous
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.